Seshadri Neervannan - 16 Dec 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Chief Operating Officer
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
16 Dec 2025
Net transactions value
$0
Form type
4
Filing time
18 Dec 2025, 16:09:20 UTC
Previous filing
20 Mar 2025
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Neervannan Seshadri Chief Operating Officer C/O TARSUS PHARMACEUTICALS, INC., 15440 LAGUNA CANYON ROAD, SUITE 160, IRVINE /s/ Jeffrey Farrow, Attorney-in-Fact 18 Dec 2025 0001827584

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Gift $0 -950 -1.2% $0.000000 79,183 16 Dec 2025 Direct F1
transaction TARS Common Stock Gift $0 +475 $0.000000 475 16 Dec 2025 By daughter F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 451 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025.
F2 This transaction involved the Reporting Person's gift of 475 shares of common stock to his daughter who shares Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by his daughter, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.